Strides Pharma Science announced that its step down subsidiary, Strides Pharma Canada Inc, Canada on 29 January 2019 has entered into an arrangement to acquire 80% stake in Pharmapar Inc. (Pharmapar), a Canada based specialised generics front end Company for consideration of CAD 4 mn (~US$ 3 mn). The board of directors of Strides have taken the same on record.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
